Author

Ron Mathôt 1

1 Academic Medical Centre, Pharmacy, Amsterdam, Netherlands

DISAPPEARANCE OF ANTI-DRUG ANTIBODIES TO INFLIXIMAB AND ADALIMUMAB AFTER ADDITION OF AN IMMUNOMODULATOR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Anne Samira Strik, Gijs R. van den Brink, Cyriel Y. Ponsioen, Ron Mathôt, Mark Lowenberg, Geert R. D'Haens

HIGH SERUM CRP PREDICTS FASTER CLEARANCE OF INFLIXIMAB AND POOR OUTCOME IN MODERATE-SEVERE ULCERATIVE COLITIS

Gijs R. van den Brink, Desiree van der Kleij, Karien Bloem, Mark Lowenberg, Cyriel Y. Ponsioen, Ron Mathôt, Geert R. D'Haens

HIGHER EARLY VEDOLIZUMAB CONCENTRATIONS AT TROUGH ARE ASSOCIATED WITH ENDOSCOPIC REMISSION AT 26 WEEKS IN CROHN’S DISEASE

Mark Lowenberg, Sophie Berends, Severine Vermeire, Ron Mathôt, Esmé Clasquin, Frank Hoentjen, Peter Bossuyt, Philippe Van Hootegem, Martine De Vos, Geert R. D'Haens, Filip Baert

HIGHER EXPOSURE TO GOLIMUMAB IS ASSOCIATED WITH ENDOSCOPIC RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE GO-KINETIC TRIAL

Sophie Berends, Anne Strik, Ron Mathôt, Geert R. D'Haens, Mark Lowenberg

UNDETECTABLE FAECAL ANTI-TNF CONCENTRATIONS AFTER SUBCUTANEOUS ADMINISTRATION IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Anne Strik, Sophie Berends, Theo Rispens, Annick de Vries, Mark Lowenberg, Krisztina Barbara Gecse, Ron Mathôt, Geert R. D'Haens

Item 1 - 5 / 5
1